摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[3,4,5-Trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate

中文名称
——
中文别名
——
英文名称
[3,4,5-Trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
英文别名
[3,4,5-trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
[3,4,5-Trihydroxy-6-(4-hydroxyphenoxy)oxan-2-yl]methyl 3,4,5-trihydroxybenzoate化学式
CAS
——
化学式
C19H20O11
mdl
——
分子量
424.4
InChiKey
KPFBMNKCSZQESS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    186
  • 氢给体数:
    7
  • 氢受体数:
    11

文献信息

  • CDK5 Inhibitors and Therapeutic Uses Thereof
    申请人:IP Nancy Yuk-Yu
    公开号:US20120270821A1
    公开(公告)日:2012-10-25
    Natural occurring inhibitors of cyclin-dependent protein kinase 5 (Cdk5), isolated from the root of Rhodiola rosea are structurally different from the known Cdk inhibitors. They show selectivity among different Cdks and efficacy to inhibit Cdk via a mixed-type of inhibition, which should lead to less toxicity and side-effects. They are useful in preventing and treating diseases and disorders associated with aberrant Cdk5 activities, such as acute and/or chronic pain, neuropathic pain, diabetes mellitus, cancer, neurodegenerative diseases and neuropathological disorders.
  • US9629863B2
    申请人:——
    公开号:US9629863B2
    公开(公告)日:2017-04-25
  • [EN] RHODIOLA ROSEA EXTRACTS AND ISOLATED COMPOUNDS AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASES<br/>[FR] EXTRAITS ET COMPOSÉS ISOLÉS D'ORPIN ROSE ET LEURS UTILISATIONS POUR LE TRAITEMENT DE MALADIES NEURODÉGÉNÉRATIVES
    申请人:UNIV HONG KONG SCIENCE & TECHN
    公开号:WO2013020368A1
    公开(公告)日:2013-02-14
    This invention relates to extract, fractions and isolated compound of Rhodiola rosea, and uses thereof for treating neuropathological and neurodegenerative diseases. The extracts and compounds of the present invention inhibit the aggregation of alpha-synuclein. In one embodiment, Rhodiola rosea extracts and compounds of the present invention can be used to treat synucleinopathies including PD, dementia with Lewy bodies, pure autonomic failure, multiple system atrophy, and Alzheimer's disease.
查看更多